Request Sample Inquiry
Lung in Vitro Model Market

Lung in Vitro Model Market

Lung in Vitro Model Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

120

Base Year:

2021

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1337

Segments Covered
  • By Type 2D Cell Models, 3D Cell Models
  • By Application Drug Screening, Toxicology, Others
  • By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: USD 275.1 Million
Revenue 2028Revenue 2028: USD 976.1 Million
Revenue CAGRRevenue CAGR (2022 - 2028): 17.1%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Lung in Vitro Model Market Share

Lung in Vitro Model Market: By Type, Application, and Region

Market Synopsis:

Global Lung in Vitro Model market is valued at USD 275.1 Million in 2021 and is projected to attain a value of USD 976.1 Million by 2028 at a CAGR of 17.1% during the forecast period, 2022–2028. The increase in awareness and attention on developing alternatives to animal testing models is a major factor contributing to the market's growth. The shift in focus is owing to two factors: first, despite their many parallels, there are distinctions between a specific animal species and humans; second, animal protection and welfare are important considerations when using animals for scientific purposes. Russell and Burch's '3Rs' should be followed, according to the Animal Welfare Institute, which states that animals should be replaced in research with alternatives, the number of animals used in experiments should be reduced, and the care and treatment of those animals who are still used in research, testing, and education should be refined.

Lung in Vitro Model Market Size, 2021 To 2028 (USD Million)

The industry's expansion will be fueled by the world's ageing population. According to the World Health Organization, the global population of people aged 60 and more will increase from 12% in 2015 to roughly 22% in 2050. With increasing age, muscle strength and physical labour capacities deteriorate. The Lung in Vitro Model market will continue to grow as more testing will be re in the near future.

Rising Prevalence of Lung Diseases and Increasing Research on Lung Disorders

For the past few years, the global Lung in Vitro Model industry has exploded in popularity. The increased prevalence of fatal lung dysfunctions such as Chronic Obstructive Pulmonary Disease (COPD), pneumonia, asthma, lung cancer, and Idiopathic Pulmonary Fibrosis is one of the key reasons driving revenue growth (IPF). To study lung illnesses and find new pharmacological therapies, researchers are using advanced Lung in Vitro Model. Revenue growth is being boosted by technological breakthroughs in cell culture and the increased acceptance of lung in vitro models rather than animal testing methods. Furthermore, growing applications in regenerative medicine are likely to create profitable prospects for global market leaders.

Shortage of Trained Professionals

Despite technological breakthroughs in cell culturing techniques and the development of 2D and 3D in vitro models, a prominent factor projected to stymie market expansion during the forecast period is the lack of trained professionals and skilled researchers to operate and set up experiments. Furthermore, poor penetration of Lung in Vitro Model, high costs of setting up in vitro procedures, and a lack of awareness about the models, particularly in developing countries, are projected to restrain the worldwide Lung in Vitro Model market's growth over the forecast period.

Market Segmentation:

The Global Lung in Vitro Model market is segmented by Type into 2D Cell Models and 3D Cell Models. Based on Application into, Drug Screening, Toxicology and Others. Based on Region, the Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Below tree is interactive. You can click the nodes to get more information.

North America is Expected to Dominate the Market

North America is expected to hold the highest proportion of the global market in 2020. The flourishing research environment and ample financing programs, such as higher finances for the National Institutes of Health (NIH) and increasing R&D activities by biotechnology and pharmaceutical businesses, are driving market growth in North America.

Key Players:

Key players operating in the Lung in Vitro Model market are: Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

The Lung in Vitro Model market is segmented as follows:

Parameter Details
Segments Covered
  • Type (2D Cell Models, 3D Cell Models)
  • Application (Drug Screening, Toxicology, Others)
  • Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Epithelix (Switzerland)
  • MatTek Corporation (US)
  • Lonza (Switzerland)
  • ATCC (US)
  • InSphero (Switzerland)
  • Emulate (US)
  • AlveoliX (Switzerland)
  • Oncotheis (Switzerland)
  • Insphero (Switzerland)
  • TissUse (Switzerland)
  • Mimetas (Netherlands)
  • and CN Bio Innovations (UK).
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

The Lung in Vitro Model market scope can be tabulated as below:

Lung in Vitro Model Market to Reach Valuation of USD 976.1 Million by 2028 - Rising Emphasis on Developing Alternatives for Animal Testing Models is Expected to Boost the Revenue for the Market
In terms of revenue, the Global Lung in Vitro Model Market is expected to reach USD 976.1 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 17.1% from 2022 to 2028. Major factor attributing to the growth of the Lung in Vitro Model Market is the increasing awareness and focus on de...
FAQ
Frequently Asked Question
  • The global Lung in Vitro Model valued at USD 275.1 Million in 2020 and is expected to reach USD 976.1 Million in 2028 growing at a CAGR of 17.1%.

  • The prominent players in the market are Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK)..

  • The market is project to grow at a CAGR of 17.1% between 2021 and 2028.

  • The driving factors of the Lung in Vitro Model include

    • Rising Prevalence of Lung Diseases and Increasing Research on Lung Disorders

  • North America was the leading regional segment of the Lung in Vitro Model in 2020.